Observational Study on GEP-and Pulm-NET Treated at FPG

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · May 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying patients with neuroendocrine tumors (NETs) that occur in the gastroenteropancreatic tract or the lungs. The researchers want to understand the characteristics of these tumors, such as their clinical signs, lab results, and genetic information, to help predict how patients might respond to treatment and what their outcomes could be. The study is currently looking for participants.

To be eligible for this trial, individuals must be at least 18 years old, have a confirmed diagnosis of gastroenteropancreatic or pulmonary NET, and show evidence of a tumor that can be surgically removed or is locally advanced or metastatic (meaning it has spread). Participants will need to sign an informed consent form and attend at least one follow-up visit after their first oncology appointment. By joining this study, participants can contribute valuable information that may improve understanding and treatment of these types of tumors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • histological diagnosis of gastroenteropancreatic or pulmonary NET
• • age ≥ 18 years;
• • radiological evidence of resectable/locally advanced/metastatic disease;
• • signing of informed consent;
• • at least one visit following the first oncological visit.
• Exclusion Criteria:
• • absence of clinical data that allow adequate definition of survival (primary endpoint of the study);
• • absence of histological diagnosis;
• • failure to sign the informed consent.